Importantly, the blockade of NaV1.5 channels expression with a specific siRNA diminishes the metastatic potential of breast cancer cells to lungs; the same effect was observed applying the drug Ranolazine, which blocks specifically NaV1.5 channels (Driffort et al., 2014). Here, SCN5A is linked to breast carcinoma.